We speak about kava the plant, kava the drink, kava the supplement, and the word “traditional” is used quite often among them. What does that mean when we say “traditional kava”?
Kava has been consumed as a medicinal, social, and ceremonial beverage for upwards of 2500 years (Lebot et al. 1993) with little to no impact on health. Only recently have we begun to see different versions of kavalactone products such as kava candies, sodas, and liquid or powdered concentrated extracts. Micronized kava also falls among this new class of “kava” (Lindstrom 2009). It is worth it to note that we have also been seeing vaporization and/or smoking products regarding kavalactones becoming available (Varlet 2016).
It’s important for us to understand that these products are not what we refer to when we talk about traditional kava, or, for that matter, kava in general. When speaking of kava, we’re speaking of Piper Methysticum rhizomes crushed/powdered, mixed with water, agitated, and strained. This definition has been accepted for the kava beverage for the duration of its existence, and it’s important that we continue to recognize it as such.
When we speak of the safety of kava, we’re speaking of the safety record of kava being consumed in this manner for thousands of years. Western countries had seen instances of injuries in the early 2000s, and it is thought that the different methods of extractions, and poor product quality may explain the additional toxicity (Whitton et al. 2003). We don’t see instances of these injuries today, however it is vitally important that we continue to refer to kava as the traditional definition, and kava products as “kavalactone products” in order to maintain this separation in terms of product quality and safety.
Lebot, V., M. Merlin, and L. Lindstrom. 1993. “Kava: The Pacific Drug. Psychoactive Plants of the World.” The Quarterly Review of Biology 68 (4): 629–30.
https://doi.org/10.1086/418411.
Lindstrom, Lamont. 2009. “Kava Pirates in Vanuatu?” International Journal of Cultural Property 16 (03): 291–308. https://doi.org/10.1017/S0940739109990208.
Varlet, V. 2016. “Drug Vaping: From the Dangers of Misuse to New Therapeutic Devices.” Toxics 4 (4).
https://doi.org/10.3390/toxics4040029.
Whitton, Peter A., Andrew Lau, Alicia Salisbury, Julie Whitehouse, and Christine S. Evans. 2003. “Kava Lactones and the Kava-Kava Controversy.” Phytochemistry 64 (3): 673–79.
https://doi.org/10.1016/s0031-9422(03)00381-9.